Search Results 31-40 of 13166 for pharmacogenetics
After nearly half a century of research, Mayo Clinic is a leader in moving pharmacogenomics into clinical practice. This year pharmacogenomics test results ...
The results from the "Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment" (RIGHT 10K) study strongly suggest that preemptive ...
One part of pharmacogenetic testing looks at the ... The study included 3016 patients who had undergone pharmacogenetics testing between 2003 and 2013.
... pharmacogenetics counselling can prevent major clinical bleeds in patients undergoing TAVR. Participation eligibility. Participant eligibility includes age ...
“Improving Outcomes Through Clinical Implementation of Pharmacogenetics” Julie A. Johnson, Pharm.D., University of Florida College of Pharmacy. 11:15 a.m. ...
The goal of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a group of patients in order ...
The Psychiatric Genomics and Pharmacogenomics Program at Mayo Clinic studies links between genetics, bipolar disorder, addiction and alcohol use disorder to ...
Recommendations for pharmacogenetic testing in clinical practice guidelines in the US. American Journal of Health-System Pharmacy. 2024; doi:10.1093/ajhp ...
Dr. Shamoun was aware of the potential value of pharmacogenomics testing, which examines how a patient's genetic makeup could impact the way he or she processes ...
The Mayo Clinic Center for Individualized Medicine's Clinomics Program accelerations the translation of genomic research into personalized patient care.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.